Engaging patients in health care epidemiology research: A case example

2019 ◽  
Vol 47 (2) ◽  
pp. 139-143 ◽  
Author(s):  
Nicole Brys ◽  
Julie A. Keating ◽  
Mary Jo Knobloch ◽  
Nasia Safdar
Keyword(s):  
Health Care ◽  
Health Care Epidemiology

scholarly journals The Society for Health Care Epidemiology of America

1998 ◽  
Vol 4 (1) ◽  
pp. 58-59
Author(s):  
Andreas Voss ◽  
C. Glenn Mayhall
Keyword(s):  
Health Care ◽  
Health Care Epidemiology

Health Care Epidemiology Perspective on the October 2006 Recommendations of the Subcommittee on Diagnosis and Management of Bronchiolitis

PEDIATRICS ◽  
2007 ◽  
Vol 120 (4) ◽  
pp. 890-892 ◽  
Author(s):  
J.-A. S. Harris ◽  
W. C. Huskins ◽  
J. M. Langley ◽  
J. D. Siegel ◽  
Keyword(s):  
Health Care ◽  
Diagnosis And Management ◽  
Health Care Epidemiology

The Role of Vancomycin and Metronidazole for the Treatment of Clostridium difficile–Associated Diarrhea

2013 ◽  
Vol 26 (5) ◽  
pp. 488-490 ◽  
Author(s):  
Serina B. Tart
Keyword(s):  
Health Care ◽  
Clostridium Difficile ◽  
Expert Panel ◽  
Low Cost ◽  
Pharmacokinetic Profile ◽  
Clinical Severity ◽  
Oral Vancomycin ◽  
Clostridium Difficile Associated Diarrhea ◽  
Health Care Epidemiology

For the treatment of Clostridium difficile–associated diarrhea (CDAD), metronidazole and vancomycin remain the most commonly used agents. The major advantage of metronidazole is its low cost, while the advantage of oral vancomycin is a more favorable pharmacokinetic profile. The epidemiology and clinical severity of CDAD have changed due to the emergence of a hypervirulent strain (BI/NAP1/027). In 2010, the Infectious Diseases Society of America/Society for Health Care Epidemiology of America expert panel defined severe CDAD and recommended oral vancomycin to treat these patients. Metronidazole remains the preferred agent for treatment of mild to moderate CDAD.

Sign in / Sign up

Export Citation Format

Share Document